Marv Enterprises, LLC, an exclusive worldwide licensor of El Paso-based biopharmaceutical company Premier Biomedical, has indicated in a recent news release that the company has received an exclusive Notice of Allowance, awarded by the U.S. Patent and Trademark Office, for twenty proprietary claims in their broad-base patent application, entitled, “Utilization of Stents for the Treatment of Blood-Borne Carcinomas.”
“This is great, but not unexpected, news for us, and affirms the novelty of our approach for developing effective treatments. We are very confident that our technology is sound and very effective in fighting many diseases that have heretofore been incurable or at least very difficult to cure. Our early lab tests bear out our assessment of the effectiveness of this technology,” explained William Hartman, President and CEO of Premier Biomedical.
Premier Biomedical works on the development of new potential therapies for multiple sclerosis (MS), traumatic brain injury and for Alzheimer, but it also develops and commercializes innovative immune-system manipulation therapies for breast cancer.
“Now, we know that our treatments are also revolutionary. Even with this good patent news, covering much of our work to date, we will continue to issue patent applications on subsequent experimental treatments to ensure proprietary content for Premier Biomedical, Inc. and our stockholders,” Mr. Hartman added.
Premier Biomedical works together with researchers at the University of Texas at El Paso as well as the U.S. Department of Defense, in a research and development effort that is seeking to specifically target solutions for the treatment of a wide range of deadly, serious diseases, such as Alzheimer’s disease, Traumatic Brain Injury, Fibromyalgia, Blood Sepsis and Viremia, Multiple Sclerosis, Cancer, Amyotrophic Lateral Sclerosis (ALS/Lou Gehrig’s Disease), and Cancer. The company has licensed its novel, experimental technology behind multiple provisional patents, both in the U.S. and as PCT Europe National Patents, pertaining to specific disease areas, such as Multiple Sclerosis, Cancer, and Sepsis.